This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Denali Therapeutics Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Richard Théolis, Jr.: Innovator in Anti-HER2 Antibodies
Introduction
Richard Théolis, Jr. is a notable inventor based in South San Francisco, CA. He has made significant contributions to the field of biotechnology, particularly in the development of anti-HER2 antibodies. His work is crucial in advancing therapeutic methods for various medical conditions.
Latest Patents
Richard Théolis, Jr. holds a patent for "ANTI-HER2 ANTIBODIES AND METHODS OF USE THEREOF." This patent represents his innovative approach to targeting HER2, a protein that can promote the growth of cancer cells. His invention is a testament to his expertise and dedication to improving healthcare solutions.
Career Highlights
Currently, Richard is associated with Denali Therapeutics Inc., a company focused on developing therapies for neurodegenerative diseases. His role at Denali Therapeutics allows him to apply his knowledge and skills in a collaborative environment, contributing to groundbreaking research and development.
Collaborations
Richard has worked alongside talented colleagues, including Do Jin Kim and Allisa Jayne Clemens. Their combined efforts in research and development have fostered an environment of innovation and creativity within their projects.
Conclusion
Richard Théolis, Jr. exemplifies the spirit of innovation in the biotechnology sector. His contributions, particularly in anti-HER2 antibodies, highlight the importance of research in advancing medical treatments. His work continues to inspire future developments in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile